TGFB1 and neoplasm: Smad4-dependent TGF-β signaling is common during tumor development and progression and can modulate cell proliferation, affect cell motility, regulate the epithelial-mesenchymal-transition (EMT) process and affect sensitivity to clinical therapy [5]–[7].